![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 25682 |
FusionGeneSummary for P4HB_CLCN3 |
![]() |
Fusion gene information | Fusion gene name: P4HB_CLCN3 | Fusion gene ID: 25682 | Hgene | Tgene | Gene symbol | P4HB | CLCN3 | Gene ID | 5034 | 1182 |
Gene name | prolyl 4-hydroxylase subunit beta | chloride voltage-gated channel 3 | |
Synonyms | CLCRP1|DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PHDB|PO4DB|PO4HB|PROHB | CLC3|ClC-3 | |
Cytomap | 17q25.3 | 4q33 | |
Type of gene | protein-coding | protein-coding | |
Description | protein disulfide-isomerasecellular thyroid hormone-binding proteincollagen prolyl 4-hydroxylase betaglutathione-insulin transhydrogenasep55procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptideprolyl 4-hydroxyla | H(+)/Cl(-) exchange transporter 3chloride channel 3chloride channel protein 3chloride channel, voltage-sensitive 3chloride transporter ClC-3 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P07237 | P51790 | |
Ensembl transtripts involved in fusion gene | ENST00000331483, ENST00000576390, ENST00000439918, ENST00000472244, | ENST00000513761, ENST00000347613, ENST00000360642, ENST00000504131, ENST00000506924, | |
Fusion gene scores | * DoF score | 25 X 9 X 12=2700 | 36 X 4 X 19=2736 |
# samples | 27 | 39 | |
** MAII score | log2(27/2700*10)=-3.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(39/2736*10)=-2.81052220113629 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: P4HB [Title/Abstract] AND CLCN3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | P4HB | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 7753822 |
Tgene | CLCN3 | GO:1902476 | chloride transmembrane transport | 11274166 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BLCA | TCGA-E7-A677-01A | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000331483 | ENST00000513761 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000331483 | ENST00000347613 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000331483 | ENST00000360642 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000331483 | ENST00000504131 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000331483 | ENST00000506924 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000576390 | ENST00000513761 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000576390 | ENST00000347613 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000576390 | ENST00000360642 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000576390 | ENST00000504131 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000576390 | ENST00000506924 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000439918 | ENST00000513761 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000439918 | ENST00000347613 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000439918 | ENST00000360642 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000439918 | ENST00000504131 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000439918 | ENST00000506924 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000472244 | ENST00000513761 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000472244 | ENST00000347613 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000472244 | ENST00000360642 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000472244 | ENST00000504131 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000472244 | ENST00000506924 | P4HB | chr17 | 79801037 | - | CLCN3 | chr4 | 170623929 | + |
Top |
FusionProtFeatures for P4HB_CLCN3 |
![]() |
Hgene | Tgene |
P4HB | CLCN3 |
This multifunctional protein catalyzes the formation,breakage and rearrangement of disulfide bonds. At the cellsurface, seems to act as a reductase that cleaves disulfide bondsof proteins attached to the cell. May therefore cause structuralmodifications of exofacial proteins. Inside the cell, seems toform/rearrange disulfide bonds of nascent proteins. At highconcentrations, functions as a chaperone that inhibits aggregationof misfolded proteins. At low concentrations, facilitatesaggregation (anti-chaperone activity). May be involved with otherchaperones in the structural modification of the TG precursor inhormone biogenesis. Also acts a structural subunit of variousenzymes such as prolyl 4-hydroxylase and microsomaltriacylglycerol transfer protein MTTP. Receptor for LGALS9; theinteraction retains P4HB at the cell surface of Th2 T helpercells, increasing disulfide reductase activity at the plasmamembrane, altering the plasma membrane redox state and enhancingcell migration (PubMed:21670307). {ECO:0000269|PubMed:10636893,ECO:0000269|PubMed:12485997, ECO:0000269|PubMed:21670307}. | Mediates the exchange of chloride ions against protons.Functions as antiporter and contributes to the acidification ofthe endosome and synaptic vesicle lumen, and may thereby affectvesicle trafficking and exocytosis. May play an important role inneuronal cell function through regulation of membrane excitabilityby protein kinase C. It could help neuronal cells to establishshort-term memory. {ECO:0000269|PubMed:11967229}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for P4HB_CLCN3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for P4HB_CLCN3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
P4HB | UBQLN1, TRIP6, EIF4A2, CUL2, ELF3, PUF60, CD2BP2, TNFRSF14, FEZ1, PTN, TG, ERO1L, ERO1LB, H2AFX, HDAC5, PSMA3, ARRB1, ARRB2, SIRT7, CUL3, CDK2, FBXO6, LMAN1, HSPA5, PDIA6, PPIB, PDIA4, HSP90B1, ATP5B, ATP5A1, SURF4, CCT4, SERPINH1, GANAB, TXNL1, CALR, TMED9, PRKCSH, CCT7, ATF2, UBL4A, CXCR4, BAG3, EGFR, CSNK2A2, HNRNPD, PARK2, CALU, ACAA2, CLNS1A, P3H1, PABPC1, TPD52L2, UBA2, UBQLN2, USP5, PFDN2, PLIN3, PSMD9, TCEAL4, AGO2, P4HB, CUL7, CCDC8, EZH2, SUZ12, RNF2, BMI1, ARAF, ESR1, TRIM4, SUCO, ZNF292, P4HA2, ZBTB2, HNRNPA1, LGALS9, ITGB3, DNAJC3, GSTO1, HSD17B10, HSPD1, NACA2, P4HA1, BCAP29, CLIC4, ENO1, ENO3, EZR, GLRX3, HSP90AA1, HSP90AB1, MSN, PCNA, PDIA3, PGD, RDX, SAFB, TKT, UQCRC2, PRPF40B, PSMA7, RCN1, UCHL3, VCP, NTRK1, EWSR1, TCTN3, CEP104, TCTN1, PPME1, CCDC6, SYMPK, EDEM1, RBM8A, CPSF3, FIP1L1, MTTP, MCM2, UBXN10, U2AF2, IAPP, VWF, GPX7, PTPRN, ACP5, DUSP13, GXYLT1, P4HA3, PTPRO, NEK7, PDHA1, SOD1, BRCA1 | CLCN3 | CLCN3, SLC9A3R1, PDZK1, GOPC, CFTR, LGALS3, LGALS8, LGALS9, LYPD3, HSPB1, TMEM9B, GGA1, TPCN2, TRIM25 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for P4HB_CLCN3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | P4HB | P07237 | DB01593 | Zinc | Protein disulfide-isomerase | small molecule | approved|investigational |
Hgene | P4HB | P07237 | DB03615 | Ribostamycin | Protein disulfide-isomerase | small molecule | approved|investigational |
Hgene | P4HB | P07237 | DB11638 | Artenimol | Protein disulfide-isomerase | small molecule | approved|investigational |
Top |
RelatedDiseases for P4HB_CLCN3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | P4HB | C0029456 | Osteoporosis | 1 | CTD_human |
Hgene | P4HB | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | P4HB | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | P4HB | C1846707 | SPINOCEREBELLAR ATAXIA 17 | 1 | CTD_human |
Hgene | P4HB | C1862178 | Cole Carpenter syndrome | 1 | ORPHANET;UNIPROT |
Tgene | CLCN3 | C0017638 | Glioma | 1 | CTD_human |
Tgene | CLCN3 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | CLCN3 | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |